Post by Mercury

When a clinical trial kit reaches an investigational site incomplete, mislabeled, or outside its validated temperature range, the downstream consequences go far beyond a single delayed shipment. From GMP-compliant assembly and EU CTR 536/2014 labeling requirements to blinded packaging protocols and depot strategy, every decision made at the outbound stage directly affects enrollment timelines and patient safety. Mercury works with sponsors and CROs to manage IMP kit distribution from first assembly to final site delivery, with 24/7 operational support and real-time visibility across every active location. Read more on our blog to learn more about what compliant clinical trial kit building actually requires and where most supply chains fall short. https://lnkd.in/dRbfqxGf #ClinicalTrials #ClinicalSupplyChain #PharmaceuticalLogistics